Kellen Olszewski
0000-0001-9691-0831
Publication & Citation Trends
Publications
0 total
Abstract PS3-09-28: Clinical investigations into the metabolic pathways of early stage hormone receptor positive/HER2 negative breast cancer
Cited by 0
Semantic Scholar
Abstract P2-08-25: FITWISE: Feasibility study of tirzepatide for weight loss intervention in early stage hormone receptor positive/HER2 negative breast cancer
Cited by 0
Semantic Scholar
Phase IB trial of high dose ascorbic acid + nab-paclitaxel + cisplatin + gemcitabine in patients with untreated metastatic pancreatic cancer
Cited by 0
Semantic Scholar
Oxidative pentose phosphate pathway is required for T cell activation and antitumor immunity.
Cited by 0
Semantic Scholar
Concurrent loss of LKB1 and KEAP1 enhances SHMT-mediated antioxidant defence in KRAS-mutant lung cancer
Cited by 19
Semantic Scholar
One-carbon unit supplementation fuels purine synthesis in tumor-infiltrating T cells and augments checkpoint blockade.
Cited by 13
Semantic Scholar
One-carbon unit supplementation fuels tumor-infiltrating T cells and augments checkpoint blockade OA
Cited by 5
Semantic Scholar
A gene expression fingerprint of C. elegans embryonic motor neurons OA
Cited by 10
Semantic Scholar
Research Topics
Malaria Research and Control
(12)
RNA modifications and cancer
(12)
Cancer, Hypoxia, and Metabolism
(9)
Metabolomics and Mass Spectrometry Studies
(9)
Ferroptosis and cancer prognosis
(9)
Affiliations
University of Life Sciences in Lublin
Vanderbilt University
Princeton University
Franklin Institute
Eon Corporation (United States)